Is CRAK or PM a better dividend investment in 2026?

CRAK currently yields 1.53% with a 5% 5-year dividend growth rate. PM yields 3.48% with 2.8% growth. The better choice depends on your goal: PM offers higher current income.

What is the dividend yield difference between CRAK and PM?

CRAK has a forward dividend yield of 1.53% ($0.76/share annually). PM yields 3.48% ($5.76/share annually). The yield gap is 1.95 percentage points.

Home › Compare › CRAK vs PM

CRAK vs PM: Dividend Comparison 2026

CRAK yields 1.53% · PM yields 3.48%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PM wins by $27.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CRAK

● Live price

1.53%

Share price

$49.40

Annual div

$0.76

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.9K

Annual income

$169.01

Full CRAK calculator →

Philip Morris International

● Live price

3.48%

Share price

$165.34

Annual div

$5.76

5Y div CAGR

17.2%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$49.6K

Annual income

$2,492.02

Full PM calculator →

Portfolio growth — CRAK vs PM

📍 PM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CRAK	PM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CRAK + PM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CRAK pays

PM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRAK

Annual income on $10K today (after 15% tax)

$130.10/yr

After 10yr DRIP, annual income (after tax)

$143.66/yr

Annual income on $10K today (after 15% tax)

$296.12/yr

After 10yr DRIP, annual income (after tax)

$2,118.22/yr

At 15% tax rate, PM beats the other by $1,974.56/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRAK + PM for your $10,000?

CRAK: 50%PM: 50%

100% PM50/50100% CRAK

Portfolio after 10yr

$35.7K

Annual income

$1,330.52/yr

Blended yield

3.72%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

CRAK

No analyst data

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$194.30

+17.5% upside vs current

Range: $180.00 — $205.00

Altman Z

4.0

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRAK buys

PM buys

No recent congressional trades found for CRAK or PM in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCRAKPM

Forward yield	1.53%	3.48% ✓
Annual dividend / share	$0.76	$5.76 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	17.2% ✓
Portfolio after 10y	$21.9K	$49.6K ✓
Annual income after 10y	$169.01	$2,492.02 ✓
Total dividends collected	$1.6K	$11.7K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: CRAK vs PM ($10,000, DRIP)

Year	CRAK Portfolio	CRAK Income/yr	PM Portfolio	PM Income/yr	Gap
1← crossover	$10,853	$153.06	$11,648	$408.29	$795.00 → PM
2	$11,768	$155.25	$13,589	$495.90	$1.8K → PM
3	$12,749	$157.32	$15,877	$603.21	$3.1K → PM
4	$13,801	$159.29	$18,580	$734.88	$4.8K → PM
5	$14,928	$161.15	$21,781	$896.75	$6.9K → PM
6	$16,136	$162.91	$25,578	$1,096.12	$9.4K → PM
7	$17,430	$164.57	$30,092	$1,342.17	$12.7K → PM
8	$18,816	$166.14	$35,470	$1,646.46	$16.7K → PM
9	$20,301	$167.62	$41,892	$2,023.58	$21.6K → PM
10	$21,891	$169.01	$49,578	$2,492.02	$27.7K → PM

CRAK vs PM: Complete Analysis 2026

CRAK — Stock

VanEck Oil Refiners ETF (CRAK) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS Global Oil Refiners Index (MVCRAKTR), which is a rules-based, modified capitalization weighted index intended to give investors a means of tracking the overall performance of companies involved in crude oil refining which may include: gasoline, diesel, jet fuel, fuel oil, naphtha, and other petrochemicals.

Full CRAK Calculator →

PM — Consumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →

📬

Get this CRAK vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRAK vs SCHD CRAK vs JEPI CRAK vs O CRAK vs KO CRAK vs MAIN CRAK vs MO CRAK vs BTI CRAK vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.